Net gamma exposure for Vir Biotechnology Inc (VIR) options was positive at the Nov 4, 2026 close, about $107.16K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for VIR, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for VIR, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for VIR, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
VIR Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is VIR gamma exposure positive or negative?
Vir Biotechnology net gamma exposure was positive on Nov 4, 2026, at $107.16K. It has been positive on 20 of the last 20 trading days.
How has VIR gamma exposure changed recently?
Vir Biotechnology net gamma exposure went from $115.38K on Oct 7, 2026 to $107.16K on Nov 4, 2026. See the VIR gamma exposure history for a longer view.
What is Vir Biotechnology Inc?
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer.